Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Safety assessment of recalled Haemophilus influenzae type b (Hib) conjugate vaccines--United States, 2007-2008.

Huang WT, Chang S, Miller ER, Woo EJ, Hoffmaster AR, Gee JE, Clark TA, Iskander JK, Ball R, Broder KR.

Pharmacoepidemiol Drug Saf. 2010 Mar;19(3):306-10. doi: 10.1002/pds.1909.

PMID:
20084617
2.

Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Nov 21;57(46):1252-5.

3.
4.

Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013.

Moro PL, Jankosky C, Menschik D, Lewis P, Duffy J, Stewart B, Shimabukuro TT.

J Pediatr. 2015 Apr;166(4):992-7. doi: 10.1016/j.jpeds.2014.12.014. Epub 2015 Jan 15.

PMID:
25598306
6.
7.

Endotoxin content in Haemophilus influenzae type b vaccine.

Ochiai M, Kataoka M, Toyoizumi H, Yamamoto A, Kamachi K, Arakawa Y, Kurata T, Horiuchi Y.

Jpn J Infect Dis. 2004 Apr;57(2):58-9.

8.
10.

Updated recommendations for use of Haemophilus influenzae type b (Hib) vaccine: reinstatement of the booster dose at ages 12-15 months.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Jun 26;58(24):673-4.

11.

Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.

Santosham M, Englund JA, McInnes P, Croll J, Thompson CM, Croll L, Glezen WP, Siber GR.

Pediatr Infect Dis J. 2001 Oct;20(10):931-40.

PMID:
11642626
12.

Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa.

von Gottberg A, de Gouveia L, Madhi SA, du Plessis M, Quan V, Soma K, Huebner R, Flannery B, Schuchat A, Klugman K.

Bull World Health Organ. 2006 Oct;84(10):811-8.

14.

The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.

Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D.

Int J Infect Dis. 2008 May;12(3):278-88. Epub 2007 Nov 5.

15.

Safety and immunogenicity of Haemophilus influenzae type B vaccine given in combination with DTwP at 6, 10 and 14 weeks of age.

Cherian T, Thomas N, Raghupathy P, Durot I, Dutta A.

Indian Pediatr. 2002 May;39(5):427-36.

PMID:
12037271
16.

Safety and immunogenicity of an indigenously developed Haemophilus influenzae type b conjugate vaccine through various phases of clinical trials.

Sharma HJ, Multani AS, Dutta AK, Joshi SM, Malik S, Bhardwaj S, Chakravarty A, Namjoshi GS, Parekh S, Verma V.

Hum Vaccin. 2009 Jul;5(7):483-7. Epub 2009 Jul 31.

PMID:
19395868
17.

In brief: A new hib booster.

[No authors listed]

Med Lett Drugs Ther. 2009 Nov 2;51(1324):88. No abstract available.

PMID:
19890246
18.

The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries.

Lagos R, Levine OS, AvendaƱo A, Horwitz I, Levine MM.

Pediatr Infect Dis J. 1998 Sep;17(9 Suppl):S139-48.

PMID:
9781748
19.

Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.

Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ.

Vaccine. 2006 Mar 10;24(11):1776-85. Epub 2005 Oct 27.

PMID:
16303216
20.

Simultaneous vaccination of Chinese applicants for a United States immigrant visa.

Hua L, Hongtao H, Shunqin W, Jinping G, Jiandong C, Zhaoliang L, Xinwen F.

Travel Med Infect Dis. 2008 May;6(3):130-6. doi: 10.1016/j.tmaid.2008.03.004.

PMID:
18486068

Supplemental Content

Support Center